Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease.
Min WeiSebastian BrandhorstMahshid ShelehchiHamed MirzaeiChia Wei ChengJulia BudniakSusan GroshenWendy Jean MackEsra GuenStefano Di BiasePinchas CohenTodd E MorganTanya DorffKurt HongAndreas MichalsenAlessandro LavianoValter Daniel LongoPublished in: Science translational medicine (2017)
Calorie restriction or changes in dietary composition can enhance healthy aging, but the inability of most subjects to adhere to chronic and extreme diets, as well as potentially adverse effects, limits their application. We randomized 100 generally healthy participants from the United States into two study arms and tested the effects of a fasting-mimicking diet (FMD)-low in calories, sugars, and protein but high in unsaturated fats-on markers/risk factors associated with aging and age-related diseases. We compared subjects who followed 3 months of an unrestricted diet to subjects who consumed the FMD for 5 consecutive days per month for 3 months. Three FMD cycles reduced body weight, trunk, and total body fat; lowered blood pressure; and decreased insulin-like growth factor 1 (IGF-1). No serious adverse effects were reported. After 3 months, control diet subjects were crossed over to the FMD program, resulting in a total of 71 subjects completing three FMD cycles. A post hoc analysis of subjects from both FMD arms showed that body mass index, blood pressure, fasting glucose, IGF-1, triglycerides, total and low-density lipoprotein cholesterol, and C-reactive protein were more beneficially affected in participants at risk for disease than in subjects who were not at risk. Thus, cycles of a 5-day FMD are safe, feasible, and effective in reducing markers/risk factors for aging and age-related diseases. Larger studies in patients with diagnosed diseases or selected on the basis of risk factors are warranted to confirm the effect of the FMD on disease prevention and treatment.
Keyphrases
- blood pressure
- weight loss
- cardiovascular disease
- blood glucose
- physical activity
- body mass index
- risk factors
- insulin resistance
- type diabetes
- squamous cell carcinoma
- clinical trial
- metabolic syndrome
- binding protein
- open label
- hypertensive patients
- adipose tissue
- coronary artery disease
- skeletal muscle
- growth hormone
- young adults
- climate change
- cell proliferation
- pi k akt
- cardiovascular events
- amino acid
- protein protein
- phase ii